AB 2009 revises plasma center personnel and donor controls
Oct 4, 2026 edition · GC-2026-0233 · Published 2026-10-04 · Version 2 · Final
AB 2009 creates a conditional personnel-change pathway for plasma centers, preserving medical-director supervision and a 30-day replacement application. It also changes director qualifications, delegated screening, paid-donor identification and digital-refractometer oversight while keeping professional-scope limits.
What happened
California enacted AB 2009 on September 27, revising plasma-center licensing and personnel rules. A change in the person in charge of biologics production need not automatically revoke a plasma collection center’s license if the owner or representative gives CDPH written notice within five days and the licensee files the replacement application within 30 days. The notice must identify the departed person, departure date, interim designee’s name and qualifications, anticipated duration and owner or representative signature. A qualified interim designee may serve no more than 30 calendar days, and the center may not operate without medical-director supervision. Failure to file the replacement application within 30 days requires revocation, subject to an additional 30-day extension CDPH may grant for good cause. The enactment is the event reported here; the applicable commencement of these provisions must be confirmed separately.
Plasma centers and auxiliaries must be directed by a licensed physician and surgeon with at least three months of plasma-center methods experience or training and other applicable qualifications. Medical directors may establish screening and donor-suitability protocols and delegate health-service duties to other licensed professionals under the department-approval, scope and supervision conditions; the provision does not expand professional scope. For paid whole-blood or component donors, identification may include photographic identification from another state, a federal agency or tribal government as well as the specified DMV identification. The law also adds supervising medical-director proficiency in digital refractometers to the testing framework and clarifies that licensed source-plasma donation centers are not blood bank depositories.
Scope and timing
- Authority status
- Final
- Applicability
- Potentially applicable
- Audience
- Health systems, Provider networks, Health-tech
- Jurisdiction
- California
Why it matters
The personnel-change exception prevents an automatic licensing consequence only when the filing and coverage conditions are met. It does not permit an unsupervised center or an indefinite interim appointment. Donation, screening and laboratory workflows also have distinct identification and qualification requirements.
Recommended action
Confirm the applicable commencement before treating the new provisions as current duties. Prepare the following for implementation at that commencement: Update personnel-departure procedures with five-day notice and 30-day application controls, qualified interim coverage and documented medical-director supervision. Review delegated duties against professional scope and department conditions. Revise paid-donor identification checks and verify the director’s digital-refractometer proficiency without treating unrelated transfusion experience as a new requirement for plasma-only services.
Sources
- AB2009 enacted final textOfficial · California Legislature · 2026-09-27 · Source review 2026-10-05
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Compliance Sweep report →